Clinical trials for Upper tract urothelial carcinoma
34 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGNCT07452432Korean Prospective Upper Tract Urothelial Carcinoma CohortSamsung Medical Center
- RECRUITINGN/ANCT07321210Radical Nephroureterectomy With vs Without Template Lymph Node Dissection in High-Risk Upper Tract Urothelial Carcinoma (T-LND UTUC): A Randomized Clinical TrialTianjin Medical University Second Hospital · PI: Changyi Quan, MD
- RECRUITINGPhase 2NCT07265947Phase 2A/B Efficacy and Safety of Dabogratinib in Participants With Low Grade Upper Tract Urothelial CarcinomaTyra Biosciences, Inc · PI: Erik T. Goluboff, MD, MBA
- RECRUITINGPhase 2NCT07225374Cisplatin-Based Chemotherapy Followed by Maintenance Avelumab in UTUCSamsung Medical Center · PI: SE HOON PARK, MD,PhD
- ACTIVE NOT RECRUITINGPhase 2NCT07492225Neoadjuvant Chemotherapy Before Surgery vs Surgery Alone for UTUC: A Randomized TrialChanghai Hospital
- RECRUITINGPhase 2NCT06356155Study of Neoadjuvant Enfortumab Vedotin and Pembrolizumab in Cisplatin-eligible Upper Tract Urothelial CancerUniversity of Michigan Rogel Cancer Center · PI: Irene Tsung
- RECRUITINGPhase 2NCT07126119Neoadjuvant Tislelizumab in Combination With Nab-Paclitaxel for UTUCTianjin Medical University Second Hospital · PI: Hailong Hu, PhD
- RECRUITINGPhase 1NCT06848868Ambulatory Flexible URS for UTUC SurveillanceChinese University of Hong Kong
- RECRUITINGPHASE1, PHASE2NCT06668493Low-grade UTUC Treated With Nadofaragene Firadenovec Administered to Renal PelvisFerring Pharmaceuticals · PI: Global Clinical Compliance
- RECRUITINGN/ANCT06805630Urine Methylation Markers in UTUCDuke University · PI: Michael Abern, MD
- RECRUITINGPhase 2NCT068234279MW2821 + Toripalimab vs 9MW2821 for 1st Line Locally Advanced or Metastatic Urothelial CarcinomaMabwell (Shanghai) Bioscience Co., Ltd.
- ACTIVE NOT RECRUITINGNCT06993779Whole-slide Image and CT Radiomics Based Deep Learning System for Prognostication Prediction in Upper Tract Urothelial CarcinomaMingzhao Xiao
- RECRUITINGN/ANCT06987552Single-Port RAS Using Da Vinci SP Surgical System for UTUC PatientsNational Taiwan University Hospital · PI: Shih-Chieh Chueh
- RECRUITINGPHASE2, PHASE3NCT06124976Multicenter Clinical Trial of ST-02 for Ablation of Upper Tract Urothelial CarcinomaUniversity of British Columbia · PI: Peter Black, Dr.
- RECRUITINGN/ANCT06262516Nephroureterectomy With and Without Lymph Node Dissection for Upper Tract Urothelial Cell CarcinomaCase Comprehensive Cancer Center · PI: Mohamed Eltemamy, MD
- ACTIVE NOT RECRUITINGNCT07155044A Comparative Study of Neoadjuvant Chemotherapy Versus Upfront Radical Surgery for Upper Tract Urothelial CarcinomaChanghai Hospital
- RECRUITINGNCT06991868A Multicenter Prospective Cohort Study on Monitoring Recurrence of Urothelial Carcinoma Based on Detection of Urinary Microscopic Residual Disease (MRD)Peking University First Hospital
- RECRUITINGPhase 2NCT06210490A Clinical Study of the Efficacy and Safety of Disitamab Vedotin in Combination With Radiotherapy for the Adjuvant Treatment of HER2 Overexpressing UTUC Patients With High Risk Factors for Recurrence After Radical SurgeryPeking University First Hospital
- RECRUITINGNCT06310759Prospective Validation Study of High Volume Urine DNA Testing in Individuals With Suspicion of Urothelial CancerTampere University Hospital · PI: Jussi Nikkola
- RECRUITINGNCT06204406Prognosis of Patients With Upper Tract Urothelial Carcinoma Receiving Kidney-sparing TherapyRenJi Hospital
- RECRUITINGPhase 2NCT05912816Combination of DV and Tislelizumab for Renal Preservation in High-risk UTUC PatientsRenJi Hospital
- RECRUITINGPhase 2NCT05868265A Study of Enfortumab Vedotin in People With Urothelial Carcinoma of the Upper Urinary TractMemorial Sloan Kettering Cancer Center · PI: Scot Niglio, MD, MS
- RECRUITINGN/ANCT06167057POST URS Chemotherapy InstillationCarmel Medical Center
- RECRUITINGPhase 2NCT05837806Efficacy and Safety of Tislelizumab in Combination With Disitamab-vedotin as Neoadjuvant Therapy for HER2-positive High-risk Upper Tract Urothelial Carcinoma (UTUC)Tianjin Medical University Second Hospital · PI: Hailong Hu, MD,PhD
- RECRUITINGPhase 2NCT05917158A Study of RC48-ADC Combined with JS001 for Postoperative Adjuvant Treatment of Upper Tract Urothelial CarcinomaJinling Hospital, China
- RECRUITINGNCT05595408Circulating and Urine Tumor DNA Dynamics Predict Minimal Residual Disease and Recurrence Risk in Locally Advanced Upper Tract Urothelial CarcinomaRenJi Hospital
- RECRUITINGNCT06598761Postoperative Adjuvant Immunotherapy Combined with Radiotherapy Versus Surgery Alone in Locally Advanced UTUCPeking University First Hospital
- RECRUITINGNCT06120374Adjuvant Radioimmunotherapy Compared With Adjuvant Chemotherapy for UTUCPeking University First Hospital · PI: Xiaoying Li, M.D.
- RECRUITINGNCT06652009Radical Radiotherapy Versus Radical Surgery for UTUCPeking University First Hospital
- RECRUITINGPhase 3NCT04865939Gemcitabine Versus Water Irrigation in Upper Tract Urothelial CarcinomaUniversity of Texas Southwestern Medical Center
- RECRUITINGNCT05438537A Comprehensive Prospective Assessment of the Physical and Biological Effects of Upper Tract Urothelial Cancer (UTUC)Chinese University of Hong Kong · PI: Jeremy Yuen-Chun TEOH, FRCS(Ed) MBBS
- RECRUITINGPhase 2NCT04617756Safety & Efficacy of Durvalumab+Neoadjuvant Chemotherapy for High-risk Urothelial Carcinoma of the Upper Urinary TractCentre Hospitalier Universitaire de Nīmes
- RECRUITINGNCT06116396Liquid Biospy for Urinary CancersIRCCS San Raffaele · PI: Massimo Alfano, PhD
- ACTIVE NOT RECRUITINGPhase 2NCT03504163Pembrolizumab (MK-3475) and Bacillus Calmette-Guérin (BCG) as First-Line Treatment for High-Risk T1 Non-Muscle-Invasive Bladder Cancer (NMIBC) and High-Grade Non-Muscle-Invasive Upper Tract Urothelial Carcinoma (NMI-UTUC)]Memorial Sloan Kettering Cancer Center · PI: Gopakumar Iyer, MD